Patti G - Search Results

1

Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19.

Spinoni EG, Mennuni M, Rognoni A, Grisafi L, Colombo C, Lio V, Renda G, Foglietta M, Petrilli I, D'Ardes D, Sainaghi PP, Aimaretti G, Bellan M, Castello L, Avanzi GC, Corte FD, Krengli M, Pirisi M, Malerba M, Capponi A, Gallina S, Pierdomenico SD, Cipollone F, Patti G; COVID-UPO Clinical Team†. Spinoni EG, et al. Among authors: patti g. Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e009375. doi: 10.1161/CIRCEP.120.009375. Epub 2021 Feb 16. Circ Arrhythm Electrophysiol. 2021. PMID: 33591815 Free PMC article. No abstract available.

2

[Management of thromboembolic risk in patients with atrial fibrillation in Italy: follow-up data from the PREFER in AF European Registry].

Renda G, Patti G, Sangiuolo R, Attena E, Malpezzi MG, De Caterina R; a nome dello Steering Committee del Registro Europeo PREFER in AF. Renda G, et al. Among authors: patti g. G Ital Cardiol (Rome). 2016 Nov;17(11):922-931. doi: 10.1714/2498.26200. G Ital Cardiol (Rome). 2016. PMID: 27996998 Italian.

3

Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.

Patti G, Lucerna M, Cavallari I, Ricottini E, Renda G, Pecen L, Romeo F, Le Heuzey JY, Zamorano JL, Kirchhof P, De Caterina R. Patti G, et al. J Am Coll Cardiol. 2017 Jan 31;69(4):409-419. doi: 10.1016/j.jacc.2016.10.069. J Am Coll Cardiol. 2017. PMID: 28126158 Free article.

4

Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.

Siller-Matula JM, Pecen L, Patti G, Lucerna M, Kirchhof P, Lesiak M, Huber K, Verheugt FWA, Lang IM, Renda G, Schnabel RB, Wachter R, Kotecha D, Sellal JM, Rohla M, Ricci F, De Caterina R; TEAM in AF group. Siller-Matula JM, et al. Among authors: patti g. Int J Cardiol. 2018 Aug 15;265:141-147. doi: 10.1016/j.ijcard.2018.04.093. Epub 2018 Apr 22. Int J Cardiol. 2018. PMID: 29706429

5

Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.

Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, Siller-Matula J, Schnabel RB, Cemin R, Kirchhof P, De Caterina R. Patti G, et al. Int J Cardiol. 2018 Nov 1;270:160-166. doi: 10.1016/j.ijcard.2018.06.098. Epub 2018 Jun 28. Int J Cardiol. 2018. PMID: 30220376

6

Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation.

Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, Siller-Matula J, Ricci F, Kirchhof P, De Caterina R. Patti G, et al. Am J Med. 2019 Jun;132(6):749-757.e5. doi: 10.1016/j.amjmed.2018.12.036. Epub 2019 Jan 19. Am J Med. 2019. PMID: 30664837 Free article.

7

Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies.

Renda G, Patti G, Lang IM, Siller-Matula JM, Hylek EM, Ambrosio G, Haas S, De Caterina R; Working Group on Thrombosis of the Italian Society of Cardiology. Renda G, et al. Among authors: patti g. Int J Cardiol. 2019 Jul 1;286:198-207. doi: 10.1016/j.ijcard.2019.02.004. Epub 2019 Feb 8. Int J Cardiol. 2019. PMID: 30777407 Review.

8

The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation.

Patti G, Sticchi A, Pasceri V, Ricci F, Renda G, Hamrefors V, Melander O, Sutton R, Engström G, De Caterina R, Fedorowski A. Patti G, et al. Diabetes Metab Res Rev. 2019 Jul;35(5):e3145. doi: 10.1002/dmrr.3145. Epub 2019 Mar 18. Diabetes Metab Res Rev. 2019. PMID: 30790434 Free article.

9

[Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment].

Calabrò P, Gragnano F, Cesaro A, Pariggiano I, Patti G, Cavallari I, Parato VM, Renda G, De Caterina R; a nome del Gruppo di Studio sulla Trombosi della Società Italiana di Cardiologia. Calabrò P, et al. Among authors: patti g. G Ital Cardiol (Rome). 2019 Jun;20(6):374-383. doi: 10.1714/3165.31471. G Ital Cardiol (Rome). 2019. PMID: 31184324 Review. Italian.

10

CHA₂DS₂VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation.

Renda G, Ricci F, Patti G, Aung N, Petersen SE, Gallina S, Hamrefors V, Melander O, Sutton R, Engstrom G, Caterina R, Fedorowski A. Renda G, et al. Among authors: patti g. Eur J Prev Cardiol. 2019 Dec;26(18):1987-1997. doi: 10.1177/2047487319868320. Epub 2019 Aug 14. Eur J Prev Cardiol. 2019. PMID: 31409109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

585 results

Search Page